Exchanging kidneys to save loved ones

There have been some amazing stories of Israelis donating a kidney to a total stranger while a relative of that stranger donates a kidney to the Israeli’s relative. Thanks to an agreement with the Czech Republic, this recently led to a six-kidney transplant exchange.

New technology to help children breathe

Researchers from Israel and the US have developed technology to allow children suffering from bronchiolitis, asthma, cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD), to breathe freely. Air pressure and acoustic pulses remove mucus from airways.

European award for stem cell investigator

Assistant Professor Yaron Fuchs of Israel’s Technion Institute is one of 27 global scientists to receive a “Young Investigators” award from the European Molecular Biology Organization. Yaron harnesses stem cell apoptosis (cell death due to injury) for driving tissue regeneration.

Phase 3 progress for Universal Flu vaccine

Israel’s BiondVax has 12,400 participants from 83 hospitals in the Phase 3 double-blind placebo-controlled trials of its Universal Flu vaccine. If successful, the new vaccine could reach pharmacies in 2023. BiondVax’s new Jerusalem facility can produce 20-40 million doses per year.

Early diagnosis of thyroid cancer

Another molecular diagnostic test has been developed by doctors at Hadassah University Medical Center in Jerusalem. It can early-diagnose thyroid cancer accurately from biopsies of small nodules that often develop on the thyroid. Previous alternatives were inaccurate or expensive.

Molecular checkups to avoid chemotherapy

A 10-year study of 1,365 Israelis indicates that chemotherapy can be avoided for most women who have early diagnosis and biopsy of the most common types of breast cancer. In 97.4% of those passing a Oncotype DX molecular checkup post-surgery, the cancer never returned.

Another breakthrough in pancreatic cancer research

Israeli scientists and doctors have induced the self-destruction of pancreatic cancer cells in mice. A small molecule, PJ34, normally used to treat stroke victims, reduced cancer cells by up to 90 percent a month. There were no adverse effects. Normal cells were unaffected.

Showcasing Israeli digital health tech

Over a thousand participants gathered in Tel Aviv for the second annual Digital.Health.Now conference. It focused on showcasing advanced Israeli innovations in telemedicine, digital healthcare, and general wellness aided by technology.

A day in the life

Last week 50 members of our synagogue were privileged to be given a tour of Emergency Service United Hatzalah’s headquarters in Jerusalem.  United Hatzalah’s volunteer EMTs arrive at the scene of an incident within three minutes, often saving lives in Israel.  Click the link to read a recent typical example.

Reducing injuries

Zone7, founded by IDF veterans, uses AI to foresee and prevent injuries to sports people. It advertises an 80% reduction in injury days and provides coaches, trainers and sports scientists with intervention strategies. Zone7 is partnering its platform with global medical company Garmin Health.